MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Comprehensive analysis of PRKN in a large Parkinson’s Disease cohort identifies causative mutations and validates population scale screening by microarray

    W. Zhu, X. Huang, E. Yoon, S. Bandres-Ciga, C. Blauwendraat, J. Cade, B. Wu, J. Brooks, J. Gibbs, D. Hernandez, D. Ehrlich, A. Singleton, D. Narendra (Bethesda, USA)

    Objective: To screen for PRKN mutations at the population scale. Background: PRKN mutations are the most common recessive cause of Parkinson’s disease (PD) and are…
  • MDS Virtual Congress 2021

    Double labeling alpha-synuclein in labial minor salivary glands in Parkinson’s disease and idiopathic RBD patients

    G. Mangone, M. Houot, S. Boluda Casas, A. Chalancon, A. Prigent, D. Seilhean, JC. Corvol, M. Vidailhet, C. Duyckaerts, B. Degos (Paris, France)

    Objective: To investigate the presence of α-Syn immunostaining in minor salivary gland biopsies (MSGB) from patients with idiopathic Parkinson's disease (PD), idiopathic Rapid Eye Movement…
  • MDS Virtual Congress 2021

    Association between Hippocampal Subfields, CSF Biomarkers, and Cognition in non-demented Parkinson’s patients

    S. Becker, O. Granert, M. Timmers, A. Pilotto, L. van Nueten, B. Roeben, G. Salvadore, W. Galpern, J. Streffer, K. Scheffler, W. Maetzler, D. Berg, I. Liepelt-Scarfone (Calgary, Canada)

    Objective: To determine whether hippocampal subfield volumes in non-demented Parkinson’s Disease (PD) are primarily predicted by cognition or CSF β-amyloid 1–42 (Aβ42) levels. Background: The…
  • MDS Virtual Congress 2021

    Structural and functional cerebellar alterations in Parkinson’s disease with postural instability and gait disorders

    A. Gardoni, E. Sarasso, S. Basaia, MA. Volonté, M. Filippi, F. Agosta (Milan, Italy)

    Objective: This study aimed at assessing structural and functional cerebellar alterations in Parkinson’s disease patients with postural instability and gait disorders (PD-PIGD). Background: Brain structures…
  • MDS Virtual Congress 2021

    Relationship Between Hyposmia and Olfactory Network Connectivity in Patients With Parkinson’s Disease

    L. Pesantez Pacheco, S. Horovitz (Bethesda, USA)

    Objective: To examine resting-state functional Magnetic Resonance Imaging in a group of Parkinson’s Disease patients, used to characterize changes in functional connectivity of the olfactory…
  • MDS Virtual Congress 2021

    Regional brain iron and gene expression variation in Parkinson’s disease

    G. Thomas, A. Zarkali, M. Ryten, K. Shmueli, AL. Gil Martinez, LA. Leyland, P. Mccolgan, J. Acosta-Cabronero, A. Lees, R. Weil (London, United Kingdom)

    Objective: To shed light on the genes underlying increased cortical iron deposition in Parkinson’s disease (PD). Background: Oxidative stress secondary to brain iron accumulation is…
  • MDS Virtual Congress 2021

    The Effect of Darkness on Gait Parameters in Patients with Parkinson’s disease.

    P. Anukoolwittaya, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To determine the effect of light on gait parameters in PD and compare to controls. Background: Falling in patients with Parkinson’s disease (PD) mostly…
  • MDS Virtual Congress 2021

    Surface EMG signal features of Parkinson’s disease may support interpretation of home-based measurement data

    S. Rissanen, M. Koivu, P. Hartikainen, A. Sinokki, P. Karjalainen, E. Pekkonen (Kuopio, Finland)

    Objective: To define reference values for surface electromyography (EMG) -based signal parameters in Parkinson's disease (PD) based on previously measured data. These reference values may…
  • MDS Virtual Congress 2021

    Is dopamine replacement therapy an addictive drug?

    V. Fleury, E. Pirondini, C. Provins, D. Benis, D. Vandeville, P. Krack (Geneva, Switzerland)

    Objective: To identify common clinical and imaging abnormalities in Parkinson's disease patients and heroin-dependent patients compared with healthy controls in order to better understand the pathophysiology…
  • MDS Virtual Congress 2021

    Obstructive sleep apnea and other vascular risk factors’ impact on Non-motor Symptoms in Parkinson’s Disease

    B. Meira, M. Fernandes, M. Salavisa, M. Saraiva, L. Conceiçao, C. Borbinha, F. Ladeira, JP. Marto, R. Barbosa, M. Mendonça, P. Bugalho (Lisbon, Portugal)

    Objective: To investigate the relationship between vascular comorbidity and non-motor symptoms in Parkinson’s Disease (PD) patients. Background: Previous studies suggested a significant association between the…
  • « Previous Page
  • 1
  • …
  • 305
  • 306
  • 307
  • 308
  • 309
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley